People With Severe Psoriasis Are at Higher Risk of Heart Disease, Researchers Say

Health & Lifestyle
263

Listen to article (english)

Translate to Spanish or other 102 languages!

Experts say people with psoriasis should have regular check-ups with their doctor. Image for illustration purposes
Experts say people with psoriasis should have regular check-ups with their doctor. Image for illustration purposes

Medical News Today

- Advertisement -
  • Researchers report that people with severe psoriasis have a higher risk of heart disease.
  • They note that typical scans for heart disease do not show blockages in the small blood vessels.
  • They say it is important for people with impaired blood flow to aggressively target heart disease risk factors.

In the most extensive study to date to look at coronary blood flow and the link between psoriasis and heart disease, scientists reported a high prevalence of coronary microvascular dysfunction in more than 30% of people with psoriasis who had no symptoms of cardiovascular disease.

Follow the link below to Medical News Today to read the full article:

https://www.medicalnewstoday.com/articles/people-with-severe-psoriasis-are-at-a-higher-risk-fof-heart-disease

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Food as Medicine: How Strawberries Can Reduce Diabetes Risk
Next article
Hidalgo County WIC Program Extending Hours of Operation Beginning Oct. 2

More Articles

Texas Adds New Condition to Mandatory Newborn Screening Tests

The Texas Department of State Health Services added a new enzyme deficiency test on June 1, 2026, to its newborn screening panel, meaning that all Texas newborns are now tested for 60 rare, genetic conditions. Tests for hearing loss and critical congenital heart disease are additional point-of-service tests typically conducted by the birthing center. 

Pancreatic Cancer Patients Gain Early Access to Experimental Drug Daraxonrasib Following Fast-Track FDA Decision

The U.S. Food and Drug Administration is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an expanded access treatment protocol (EAP) for its experimental pancreatic cancer drug, daraxonrasib.

STHS GME Consortium Encourages Community to “Walk with a Doc”, June 6th

Mega Doctor News In an era defined by high-intensity workouts, wearable fitness trackers and advanced training techniques, one of simplest...

Study: Menopause Hormone Therapy Declines Nationwide Despite Proven Benefits

Hormone therapy use among women in the U.S. remains low, even though it's an effective treatment for many menopause symptoms, according to a new Mayo Clinic study published in Mayo Clinic Proceedings.
- Advertisement -